Laboratory evaluation of hypercoagulable states

E. M. Van Cott, Michael Laposata

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The number of well-characterized hereditary and acquired hypercoagulable conditions is increasing, such that in many thrombophilic patients, the laboratory can now identify a hypercoagulable condition. This review describes the currently known hypercoagulable states that predispose patients to venous, and in some instances, arterial thrombosis. For each condition, the discussion includes the incidence, magnitude of the thrombotic risk in the general population in comparison with symptomatic families, synergistic interactions among the various hypercoagulable conditions, molecular pathogenesis, and interpretation of laboratory test results. In addition, recommendations for laboratory testing are summarized.

Original languageEnglish (US)
Pages (from-to)1141-1166
Number of pages26
JournalHematology/Oncology Clinics of North America
Volume12
Issue number6
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Thrombosis
Incidence
Population

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Laboratory evaluation of hypercoagulable states. / Van Cott, E. M.; Laposata, Michael.

In: Hematology/Oncology Clinics of North America, Vol. 12, No. 6, 1998, p. 1141-1166.

Research output: Contribution to journalArticle

@article{ca4ae2c1a47544b9ba8ef88976298751,
title = "Laboratory evaluation of hypercoagulable states",
abstract = "The number of well-characterized hereditary and acquired hypercoagulable conditions is increasing, such that in many thrombophilic patients, the laboratory can now identify a hypercoagulable condition. This review describes the currently known hypercoagulable states that predispose patients to venous, and in some instances, arterial thrombosis. For each condition, the discussion includes the incidence, magnitude of the thrombotic risk in the general population in comparison with symptomatic families, synergistic interactions among the various hypercoagulable conditions, molecular pathogenesis, and interpretation of laboratory test results. In addition, recommendations for laboratory testing are summarized.",
author = "{Van Cott}, {E. M.} and Michael Laposata",
year = "1998",
doi = "10.1016/S0889-8588(05)70047-2",
language = "English (US)",
volume = "12",
pages = "1141--1166",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Laboratory evaluation of hypercoagulable states

AU - Van Cott, E. M.

AU - Laposata, Michael

PY - 1998

Y1 - 1998

N2 - The number of well-characterized hereditary and acquired hypercoagulable conditions is increasing, such that in many thrombophilic patients, the laboratory can now identify a hypercoagulable condition. This review describes the currently known hypercoagulable states that predispose patients to venous, and in some instances, arterial thrombosis. For each condition, the discussion includes the incidence, magnitude of the thrombotic risk in the general population in comparison with symptomatic families, synergistic interactions among the various hypercoagulable conditions, molecular pathogenesis, and interpretation of laboratory test results. In addition, recommendations for laboratory testing are summarized.

AB - The number of well-characterized hereditary and acquired hypercoagulable conditions is increasing, such that in many thrombophilic patients, the laboratory can now identify a hypercoagulable condition. This review describes the currently known hypercoagulable states that predispose patients to venous, and in some instances, arterial thrombosis. For each condition, the discussion includes the incidence, magnitude of the thrombotic risk in the general population in comparison with symptomatic families, synergistic interactions among the various hypercoagulable conditions, molecular pathogenesis, and interpretation of laboratory test results. In addition, recommendations for laboratory testing are summarized.

UR - http://www.scopus.com/inward/record.url?scp=0032412683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032412683&partnerID=8YFLogxK

U2 - 10.1016/S0889-8588(05)70047-2

DO - 10.1016/S0889-8588(05)70047-2

M3 - Article

C2 - 9922930

AN - SCOPUS:0032412683

VL - 12

SP - 1141

EP - 1166

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 6

ER -